Recent HIV/AIDS News from CDC, NIH, and FDA
News from CDC
May 21, 2014: New CDC Campaign Inspires Life-Saving Conversations About HIV
“The Centers for Disease Control and Prevention today launched Start Talking. Stop HIV., a new national communication campaign encouraging gay and bisexual men to talk openly with their sexual partners about HIV risk and prevention strategies.”
News from NIH
May 19, 2014: 2014 Avant-Garde Awards Focus on Strengthening the Immune System
“With proposals ranging from enhancing the immune system’s ability to fight HIV infection to improving long-term immune health in HIV-infected drug users, three scientists have been chosen to receive the 2014 Avant-Garde Award for HIV/AIDS Research from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health.”
News from FDA
May 12, 2014: Tivicay (Dolutegravir) Labeling Update
“On May 12, 2014, FDA approved updates to the TIVICAY (dolutegravir) product labeling with information regarding the effect of dolutegravir on renal transporters and drug-drug interaction data between dolutegravir and calcium carbonate or ferrous fumarate.”
View the AIDSinfo patient fact sheet on dolutegravir.
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - Category: Infectious Diseases Source Type: news